Drug Shortage Report for TWYNSTA

Last updated on 2023-02-17 History
Report ID 178725
Drug Identification Number 02371049
Brand name TWYNSTA
Common or Proper name Twynsta 80+5mg Tablets
Company Name BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Market Status MARKETED
Active Ingredient(s) AMLODIPINE TELMISARTAN
Strength(s) 5MG 80MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 4x7
ATC code C09DB
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Demand increase for the drug.
Anticipated start date 2022-12-16
Actual start date 2022-12-16
Estimated end date 2023-02-17
Actual end date 2023-02-16
Shortage status Resolved
Updated date 2023-02-17
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 5180 SOUTH SERVICE ROAD
BURLINGTON, ONTARIO
CANADA L7L 5H4
Company contact information 1800 263 2425

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2023-02-17 English Compare
v10 2023-02-16 French Compare
v9 2023-02-16 English Compare
v8 2023-01-27 French Compare
v7 2023-01-27 English Compare
v6 2023-01-27 English Compare
v5 2023-01-27 English Compare
v4 2023-01-27 English Compare
v3 2022-12-17 English Compare
v2 2022-12-16 French Compare
v1 2022-12-16 English Compare

Showing 1 to 11 of 11